Zobrazeno 1 - 10
of 136
pro vyhledávání: '"Lale Atahan"'
Autor:
Gülsev Kale, Nur Olgun, Asim Yoruk, Serdar Sander, Sergülen Dervişoğlu, Inci Ayan, Emin Darendeliler, Inci Yildiz, Gülyüz Atkovar, Ayhan Dagdemir, Gulten Karpuzoglu, Gülnur Tokuç, Funda Corapcioglu, Cenk Büyükünal, G. Burça Aydın, Nilgun Yaris, Bilgehan Yalçın, Atilla Tanyeli, Volkan Hazar, Oznur Duzovali, Mustafa Melikoglu, Nebil Büyükpamukçu, Münevver Büyükpamukçu, Aynur Oguz, Lale Atahan, Uğur Kuyumcuoğlu, Ferhan Akici, Naciye Özşeker, Canan Akyüz
Publikováno v:
Pediatric Hematology and Oncology. 27:161-178
melikoglu, mustafa/0000-0001-9646-3787; Aydin, Burca/0000-0002-6013-6271 WOS: 000278808800001 PubMed: 20367260 Aim: To standardize diagnosis and treatment of childhood Wilms tumor (WT) in Turkey. Methods and patients: Between 1998 and 2006, WT patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71576a8b993fd43480fbbec0b8dd190c
https://doi.org/10.3109/08880010903447375
https://doi.org/10.3109/08880010903447375
Publikováno v:
The International Journal of Biological Markers. 22:194-199
Recent studies suggest that plasma Epstein-Barr virus (EBV) DNA may reflect tumor burden in patients with nasopharyngeal cancer. A prospective study was initiated to investigate this correlation in 125 patients (34 pretreatment [Group A], 78 in remis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43a064b183028caeaf901d456e775820
https://doi.org/10.1177/172460080702200305
https://doi.org/10.1177/172460080702200305
Autor:
Mehmet Faruk Köse, Gökhan Tulunay, Nilüfer Güler, Berrin Pehlivan, Ferah Yildiz, Enis Ozyar, Ayse Ayhan, Mine Genc, K Yuce, Türkan Küçükali, Ibtisam Lale Atahan
Publikováno v:
International Journal of Gynecological Cancer. 17:813-820
To evaluate the efficacy of postoperative radiotherapy and to investigate prognostic factors for early-stage cervical cancer patients. From December 1993 to December 2001, 141 patients with stage I-II cervical cancer without para-aortic lymph node (L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5579e2c510508abc1399433a66c3f5b2
https://doi.org/10.1111/j.1525-1438.2007.00887.x
https://doi.org/10.1111/j.1525-1438.2007.00887.x
Publikováno v:
International Journal of Gynecological Cancer. 17:833-842
This study evaluates treatment outcomes and possible prognostic factors of inoperable cervical cancer patients treated with external beam radiotherapy (EBRT) and high-dose rate brachytherapy (HDR BRT). Between 1993 and 2000, 183 patients with cervica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::299f81cce3f442530751830dc076673c
https://doi.org/10.1111/j.1525-1438.2007.00895.x
https://doi.org/10.1111/j.1525-1438.2007.00895.x
Publikováno v:
Medical Oncology. 24:239-243
This study is designed to assess the toxicity and therapeutic effectiveness of concurrent gemcitabine and radiotherapy in patients with unresectable pancreatic cancer. Concurrent gemcitabine (400 mg/m2/wk) in six weekly cycles starting on d 1 of radi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08f64a9747c85910ed5764902b2bf36e
https://doi.org/10.1007/bf02698046
https://doi.org/10.1007/bf02698046
Autor:
Yavuz Anacak, Margarita Martin, Luciano Scandolaro, Mahmut Ozsahin, Ufuk Abacioglu, Ibtisam Lale Atahan, Fadime Akman, S. Laskar, Enis Ozyar, Robert C. Miller, Eva Szutowicz, Ugur Selek, Ömer Uzel, Süreyya Sarihan, Murat Caloglu, Suzanne L. Wolden, Sopiha Polychronopoulou, Miriam Ben-Arush
Publikováno v:
Radiotherapy and Oncology. 81:39-46
Purpose This Rare Cancer Network (RCN) study was performed in pediatric nasopharyngeal carcinoma (PNPC) patients to evaluate the optimal dose of radiotherapy and to determine prognostic factors. Patients and Methods The study included 165 patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9317797a7e3f993891dcec579a098dd
https://doi.org/10.1016/j.radonc.2006.08.019
https://doi.org/10.1016/j.radonc.2006.08.019
Autor:
Nebil Büyükpamukçu, Tezer Kutluk, Canan Akyüz, Ali Varan, Lale Atahan, Münevver Büyükpamukçu, Melda Çağlar
Publikováno v:
Journal of Pediatric Hematology/Oncology. 28:423-426
To analyze changes in the overall survival (OS) rate of children with Wilms tumor treated in a single institute over nearly 30 years. This study included 327 children with a newly diagnosed Wilms tumor. Their median age was 3 years, and the male:fema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c055242cee7c57db6d802fa1d484375
https://doi.org/10.1097/01.mph.0000212948.05232.7a
https://doi.org/10.1097/01.mph.0000212948.05232.7a
Autor:
Tezer Kutluk, Bilgehan Yalçın, Münevver Büyükpamukçu, Ali Varan, Canan Akyüz, Serhan Küpeli, I. Lale Atahan, Enis Ozyar
Publikováno v:
Pediatric Blood & Cancer. 46:454-458
Background To evaluate the clinical characteristics, treatment regimens, survival, and late complications in patients with nasopharyngeal carcinoma. Procedure Eighty-four patients diagnosed with nasopharyngeal carcinoma between 1972 and 2002 were ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12e11a05842bf25db4ab12d09387c67f
https://doi.org/10.1002/pbc.20433
https://doi.org/10.1002/pbc.20433
Autor:
Münevver Büyükpamukçu, Canan Akyüz, Ali Varan, M. Tezer Kutluk, Bilgehan Yalçın, I. Lale Atahan
Publikováno v:
Pediatric Hematology and Oncology. 22:589-596
The authors report 3 cases of Hodgkin's disease with intracranial involvement. The patients were 4, 12, and 15 years old (male/female=1/2). Initially, they were treated with ABVD or COPP chemotherapies and low-dose involved field radiotherapy. Intrac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2298a370f3ff1a59ae880ae3d897600c
https://doi.org/10.1080/08880010500198863
https://doi.org/10.1080/08880010500198863
Autor:
Kutlu Erol, Lale Atahan, Demir Ali Onat, Yavuz Ozisik, Esmen Baltali, Kadri Altundag, Nilüfer Güler, Iskender Sayek, Mustafa Cengiz, Gülten Tekuzman
Publikováno v:
Oncology Research and Treatment. 28:81-85
Our primary objective was to determine the response rate; secondary objectives were to assess the toxicity rate, and disease-free and overall survival rates in patients with locally advanced breast cancer (LABC) receiving a cyclophosphamide (500 mg/m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c0859b8c8171b1a3afe07cd6d3c6787
https://doi.org/10.1159/000082951
https://doi.org/10.1159/000082951